Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2012-03-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00432-011-1145-3PMID 22398780PMCID PMC11824218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2.

  2011cited by this paper
• Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells

  2010cited by this paper
• Minireview: thyroid hormone transporters: the knowns and the unknowns.

  2010cited by this paper
• Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines.

  2010cited by this paper
• Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.

  2009cited by this paper
• Estrogen Receptor-β as a Potential Target for Colon Cancer Prevention: Chemoprevention of Azoxymethane-Induced Colon Carcinogenesis by Raloxifene in F344 Rats

  2009cited by this paper
• The use of tamoxifen and raloxifene for the prevention of breast cancer.

  2009cited by this paper
• Gene Therapy with the Angiogenesis Inhibitor Endostatin in an Orthotopic Lung Cancer Murine Model

  2009cited by this paper
• The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line.

  2009cited by this paper
• Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

  2008cited by this paper
• Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells

  2008cited by this paper
• Expression of Estrogen Receptor β in Colon Cancer Progression

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.

  2007cited by this paper
• Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells

  2006cited by this paper
• Raloxifene works as well as tamoxifen in preventing invasive breast cancer.

  2006cited by this paper
• Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging.

  2005cited by this paper
• ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components.

  2005cited by this paper
• The price tag on progress--chemotherapy for colorectal cancer.

  2004cited by this paper
• Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.

  2004cited by this paper
• Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

  2004cited by this paper
• Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

  2004cited by this paper
• Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

  2003cited by this paper
• Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

  2003cited by this paper
• Defining the "S" in SERMs

  2002cited by this paper
• A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblasts.

  2002cited by this paper
• Biomedicine. Defining the "S" in SERMs.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

  2001cited by this paper
• Selective loss of estrogen receptor β in malignant human colon

  2000cited by this paper
• Selective loss of estrogen receptor beta in malignant human colon.

  2000cited by this paper
• Chemoprevention of colorectal cancer.

  2000cited by this paper
• The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

  1999cited by this paper
• An estrogen receptor basis for raloxifene action in bone.

  1999cited by this paper
• Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

  1999cited by this paper
• Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.

  1999cited by this paper
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

  1998cited by this paper
• Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β.

  1998cited by this paper
• Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas

  1997cited by this paper
• Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells.

  1986cited by this paper

• Raloxifene, a SERM targets PD-L1: an in-silico study.

  2023cites this paper
• WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer

  2023cites this paper
• Therapeutic Strategies and Potential Actions of Female Sex Steroid Hormones and Their Receptors in Colon Cancer Based on Preclinical Studies

  2022influential citation
• Estrogen Receptors in Colorectal Cancer: Facts, Novelties and Perspectives

  2021cites this paper
• Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling

  2020cites this paper
• Silencing of estrogen receptor β promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway

  2019cites this paper
• Silencing of estrogen receptor β promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway

  2019cites this paper
• Silencing of estrogen receptor β promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway

  2019cites this paper
• Estrogen Receptor Beta Inhibits The Proliferation, Migration, And Angiogenesis Of Gastric Cancer Cells Through Inhibiting Nuclear Factor-Kappa B Signaling

  2019cites this paper
• OTT_A_214529 9153..9164

  2019cites this paper
• Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma

  2018cites this paper
• Synthesis and biological evaluation of novel 5-chloro-N-(4-sulfamoylbenzyl) salicylamide derivatives as tubulin polymerization inhibitors.

  2018cites this paper
• Serum miR-129 functions as a biomarker for colorectal cancer by targeting estrogen receptor (ER) β.

  2017cites this paper
• Molecular and Physiological Roles of Estrogen Receptor

  2017cites this paper
• The role of estrogen receptors in intestinal homeostasis and disease

  2016cites this paper
• Estrogen receptor beta as target for colorectal cancer prevention.

  2016cites this paper
• Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis

  2016cites this paper
• Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity

  2015cites this paper
• Estrogen Receptors and Their Implications in Colorectal Carcinogenesis

  2015cites this paper
• 17β-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line.

  2015cites this paper
• Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model.

  2015cites this paper
• Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.

  2015cites this paper
• Use of rodents as models of human diseases

  2014cites this paper
• Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy

  2014cites this paper
• Oestrogen receptor‐beta as a potential target for treatment in advanced colorectal cancer: a pilot study

  2014cites this paper
• Reductions in Myeloid-Derived Suppressor Cells and Lung Metastases using AZD4547 Treatment of a Metastatic Murine Breast Tumor Model

  2014cites this paper
• Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells.

  2013cites this paper
• Estrogen receptor α and β in the normal immune system and in lymphoid malignancies.

  2013cites this paper
• Estrogen Receptor beta in Colorectal Cancer Prevention: Do we have Conclusive Proof?

  2013cites this paper
• The SERM raloxifene improves diaphyseal fracture healing in mice

  2013cites this paper
• Beyond breast carcinomas: the attenuating effect on tumor growth in other systemic malignancies by raloxifene

  2013cites this paper
• Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer

  2012cites this paper